Toshihide Kashihara Selected Research

1,4-dihydropyridine (dihydropyridine)

6/2012

Two mechanistically distinct effects of dihydropyridine nifedipine on CaV1.2 L-type Ca²⁺ channels revealed by Timothy syndrome mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshihide Kashihara Research Topics

Disease

10	Heart Failure 01/2022 - 01/2011
4	Ventricular Tachycardia 01/2020 - 01/2011
3	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2014 - 01/2011
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 03/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2019
2	Fibrosis (Cirrhosis) 01/2014 - 01/2012
2	Cardiac Arrhythmias (Arrythmia) 01/2014 - 01/2012
1	Diabetic Cardiomyopathies 01/2021
1	Hypertension (High Blood Pressure) 01/2019
1	Neuralgia (Stump Neuralgia) 01/2019
1	Pain (Aches) 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Atherosclerosis 01/2018
1	Myocardial Infarction 04/2015
1	Infarction (Infarctions) 04/2015
1	Ischemia 01/2014
1	Hypertrophy 01/2014
1	Timothy syndrome 06/2012
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2012
1	Tachycardia (Tachyarrhythmias) 01/2011

Drug/Important Bio-Agent (IBA)

3	Polyvinyl Chloride (PVC)IBA 01/2014 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2012
2	ArrestinIBA 11/2020 - 01/2017
2	Angiotensin IIIBA 01/2019 - 01/2014
2	Sulfoglycosphingolipids (Sulfatides)IBA 01/2019 - 01/2019
2	Adrenergic Agents (Adrenergic Drugs)IBA 02/2014 - 03/2011
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2012 - 03/2011
1	Serine (L-Serine)FDA Link 01/2022
1	Aspartic Acid (Aspartate)FDA Link 01/2022
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	malic acid (malate)IBA 01/2022
1	AntioxidantsIBA 01/2021
1	Sar-Arg-Val-Tyr-Ile-His-Pro-Ala-OHIBA 11/2020
1	Pharmaceutical PreparationsIBA 11/2020
1	GlycosphingolipidsIBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	ProstaglandinsIBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	IvabradineIBA 01/2019
1	grapiprantIBA 01/2019
1	Platelet-Derived Growth FactorIBA 01/2018
1	CytokinesIBA 01/2018
1	Coloring Agents (Dyes)IBA 04/2015
1	Cholinergic Agents (Cholinergics)IBA 02/2014
1	Atropine FDA LinkGeneric 02/2014
1	1,3-dipropyl-8-cyclopentylxanthineIBA 02/2014
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 02/2014
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 02/2014
1	Type 1 Angiotensin ReceptorIBA 01/2014
1	PhlorhizinIBA 01/2014
1	olmesartanIBA 01/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2013
1	1,4-dihydropyridine (dihydropyridine)IBA 06/2012
1	Nifedipine (Adalat)FDA LinkGeneric 06/2012
1	Nicorandil (SG 75)IBA 01/2012
1	Protein Kinases (Protein Kinase)IBA 03/2011
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 03/2011
1	Diacylglycerol KinaseIBA 01/2011

Therapy/Procedure

2	Transplantation 01/2020 - 04/2015
2	Therapeutics 01/2019 - 01/2017
1	Renal Dialysis (Hemodialysis) 01/2019
1	Nephrectomy 01/2019
1	Oral Administration 01/2019